Overexpression of Bcl-2 in T cells affects insulitis in the nonobese diabetic mouse

Scandinavian Journal of Immunology

Volumn 57, Issue 4, 2003, Pages 342-349

  Rietz, C ^a   Screpanti, V ^b   Brenden, N ^c   Bohme J ^d   Fernandez C ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c HAGEDORN RESEARCH INSTITUTE   (Denmark)

^d SÖDERTÖRN UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; ENHANCER REGION; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; INSULITIS; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL SURVIVAL; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; FEMALE; GENE EXPRESSION REGULATION; GENES, BCL-2; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, TRANSGENIC; PANCREAS; PROTO-ONCOGENE PROTEINS C-BCL-2; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0037384047     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01244.x     Document Type: Article

References (37)

1. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996;85:291-7.
2. Kikutani H, Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 1992;51:285-322.
3. Bedossa P, Bendelac A, Bach J-F, Carnaud C. Syngeneic T cell transfer of diabetes into NOD newborn mice: in situ studies of the autoimmune steps leading to insulin-producing cell destruction. Eur J Immunol 1989;19:1947-51.
4. Forsgren S, Andersson Å, Hillörn V, Söderström Å, Holmberg D. Immunoglobulin-mediated prevention of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Scand J Immunol 1991;34:445-51.
5. null mice. J Exp Med 1996;184:2049-53.
6. H gene utilisation in patients with established insulin dependent diabetes mellitus. J Autoimmun 1997;10:157-63.
7. Bendelac A, Boitard C, Bedossa P et al. Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 1988;141:2625-8.
8. g7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet β cells of nonobese diabetic mice. J Immunol 1999;163:743-50.
9. Akashi T, Nagafuchi S, Anzai K et al. Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice. Int Immunol 1997;9:1159-64.
10. Yang M, Charlton B, Gautam AM. Development of insulitis and diabetes in B cell deficient NOD mice. J Autoimmun 1997;10:257-60.
11. Hattori M, Buse JB, Jackson RA et al. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex. Science 1986;231:733-5.
12. Achea-Orbea H, McDevitt HO. The first external chain of the non-obese diabetic mouse class II, I-A b chain is unique. Proc Natl Acad Sci USA 1987;84:2435-9.
13. Nishimoto H, Kikutani H, Yamamura K-I, Kishimoto T. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 1987;28:432-4.
14. Böhme J, Schubaur B, Kanagawa O, Benoist C, Mathis D. MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 1990;249:293-5.
15. Slattery RM, Kjer-Nielsen L, Allison J et al. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature 1990;345:724.
16. Lund T, O'Reilly L, Hutchings P et al. Prevention of insulin dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chain. Nature 1990;345:727-9.
17. Ghosh S, Palmer SM, Rodrigues NR et al. Polygenic control of autoimmune diabetes in nonobese diabeteic mice. Nat Genet 1993;4:404-9.
18. Cornall RJ, Prins J-B, Todd JA et al. Type 1 diabetes in mice is linked to the interleukin-1 receptor and Lsh/ItyBcg genes on chromosome 1. Nature 1991;353:262-4.
19. Colucci F, Bergman M-L, Penha-Gonçalves C, Cilio CM. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc Natl Acad Sci USA 1997;94:8670-4.
20. Garchon H-J, Bedossa P, Eloy L, Bach J-F. Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in nonobese diabetic mice. Nature 1991;353:260-2.
21. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Nad Acad Sci USA 1986;83:5214-8.
22. Cory S. Regulation of lymphocyte survival by the bcl-2 gene family. Annu Rev Immunol 1995;13:513-43.
23. Bossy-Wetzel E, Green DR. Apoptosis: checkpoint at the mitochondrial frontier. Mutat Res 1999;434:243-51.
24. Leijon K, Hammarström B, Holmberg D. Non-obese diabetic (NOD) mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 1994;6:339-45.
25. Garchon H-J, Luan J-J, Eloy L, Bedossa P, Bach J-F. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 1994;24:380-4.
26. Lamhamedi-Cherradi S-E, Luan J-J, Eloy L, Fluteau G, Bach J-F, Garchon H-J. Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x. Diabetologia 1998;41:178-84.
27. Strasser A, Harris AW, Vaux DL et al. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr Top Microbiol Immunol 1990;166:175-81.
28. Strasser A, Whittingham S, Vaux DL et al. Enforced BCL-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 1991;88:8661-5.
29. Strasser A, Harris AW, Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991;67:889-99.
30. André I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D. Checkpoints in the progression of autoimmune disease: Lessons from diabetes models. Proc Natl Acad Sci USA 1996;93:2260-3.
31. Pilstrom B, Böhme J. Alleviation of insulitis in NOD mice is associated with expression of transgenic MHC E molecules on primary antigen presenting cells. Immunology 1997;90:483-8.
32. Bendelac A, Carnaud C, Boitard C, Bach JF. Syngenic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells. J Exp Med 1987;166:823-32.
33. Tian J, Lehman PV, Kaufmann DL. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J Exp Med 1997;186:2039-43.
34. Boitard C, Yasunami R, Dardenne M, Bach J. T-cell mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J Exp Med 1989;169:1669-80.
35. O'Reilly L, Huang D, Strasser A. The cell death inhibitor Bcl-2 and its homologues influence control of cell cycle entry. EMBO J 1996;15:6979-90.
36. Mazel S, Burtrum D, Petrie H. Regulation of cell cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death. J Exp Med 1996;183:2219-26.
37. Linette GP, Li Y, Roth K, Korsmeyer SJ. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 1996;93:9545-52.